The merger is on track for shareholder vote on July 16. The stock should trade near the deal price. Monitor for any further litigation or vote results. No trading opportunity unless the deal breaks.
Price Chart
Executive Summary
Cross Country Healthcare filed an 8-K to voluntarily supplement its proxy statement with additional disclosures in response to two shareholder lawsuits challenging the merger. The special meeting to approve the going-private acquisition by Knox Lane remains scheduled for July 16, 2026, with closing expected in Q3 2026. The supplemental disclosures include details on post-closing consulting arrangements for certain executives and additional financial analysis from BofA Securities, but do not change the merger terms or consideration.
Key Facts
- Special meeting to approve merger scheduled for July 16, 2026
- Two lawsuits filed (Malone and Walsh actions) alleging deficient proxy disclosures
- Company voluntarily supplementing proxy with additional disclosures; denies allegations
- BofA Securities fairness analysis details: net cash ~$106.2M, fully diluted shares ~33.006M
- BofA applied EV/EBITDA multiples of 4.8x-7.5x (public comps) and 9.0x-11.5x (precedent transactions)
- DCF terminal value based on $25M unlevered free cash flow, 3.0%-4.0% perpetuity growth, 9.0%-11.0% WACC
- Analyst price targets discounted to $9.09-$13.64 per share
- Knox Lane initiated post-closing consulting discussions with CEO Kevin Clark, Mr. Burns, and Ms. Ball on May 14, 2026
- Merger expected to close in Q3 2026
Financial Impact
No direct financial impact; supplemental disclosures do not alter merger consideration or terms.
Risk Factors
- Shareholder vote could fail or be delayed
- Litigation could delay closing despite supplemental disclosures
- Regulatory approvals not yet disclosed as a condition to closing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0000950103-26-010220 |
| Document: 0000950103-26-010220-index-headers.html | 0000950103-26-010220 |
| Document: 0000950103-26-010220-index.html | 0000950103-26-010220 |
| Document: 0000950103-26-010220.txt | 0000950103-26-010220 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Jul 6, 2026 16w ago | 425 | $13.20 | awaiting T+20 | — | — |
Jul 6, 2026 16w ago | 8-K | $13.20 | awaiting T+20 | — | — |
Jun 15, 2026 19w ago | DEFM14A | $13.18 $13.22 | ▲ +0.30% | ▲ +0.10% | — |
Jun 3, 2026 20w ago | PREM14A | $13.19 $13.20 | ▲ +0.08% | ▲ +1.45% | — |
May 7, 2026 24w ago | DEFA14A | $13.18 $13.18 | · 0.00% | ▼ −0.02% | — |
May 7, 2026 24w ago | DEFA14A | $13.18 $13.18 | · 0.00% | ▼ −0.02% | — |
May 7, 2026 24w ago | 8-K | $13.18 $13.18 | · 0.00% | ▼ −0.02% | — |
May 7, 2026 24w ago | 8-K | $13.09 $13.12 | ▲ +0.23% | ▼ −2.91% | — |
Apr 17, 2026 27w ago | 8-K | $9.96 $13.10 | ▲ +31.53% | ▲ +27.32% | — |
Mar 4, 2026 33w ago | 8-K | $9.89 $9.18 | ▲ +7.18% | ▲ +3.39% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers